Senior expertise in medical affairs & pharmacovigilance
Senior expertise in medical affairs & pharmacovigilance
Senior expertise in medical affairs & pharmacovigilance
Senior expertise in medical affairs & pharmacovigilance
When the clinical value of a therapy must be sustained throughout its lifecycle.
The clinical value of a therapy is not determined solely at the point of regulatory approval. It is continuously reinforced through medical insight, safety data, and real-world experience across the entire product lifecycle.
Sustaining a robust benefit–risk profile requires senior expertise capable of integrating scientific evidence, safety data, real-world insights, and medical decision-making. This expertise is critical across initiatives including:
Positioning Medical Affairs, pharmacovigilance, and patient safety within an integrated medical governance framework
Alignment of medical, scientific, and safety functions
Strengthening evidence generation and medical decision-making
Management of pharmacovigilance, benefit–risk assessment, and safety governance
Embedding patient safety, medical integrity, and long-term stakeholder confidence
When the clinical value of a therapy must be sustained throughout its lifecycle.
The clinical value of a therapy is not determined solely at the point of regulatory approval. It is continuously reinforced through medical insight, safety data, and real-world experience across the entire product lifecycle.
Sustaining a robust benefit–risk profile requires senior expertise capable of integrating scientific evidence, safety data, real-world insights, and medical decision-making. This expertise is critical across initiatives including:
Positioning Medical Affairs, pharmacovigilance, and patient safety within an integrated medical governance framework
Alignment of medical, scientific, and safety functions
Strengthening evidence generation and medical decision-making
Management of pharmacovigilance, benefit–risk assessment, and safety governance
Embedding patient safety, medical integrity, and long-term stakeholder confidence
When the clinical value of a therapy must be sustained throughout its lifecycle.
The clinical value of a therapy is not determined solely at the point of regulatory approval. It is continuously reinforced through medical insight, safety data, and real-world experience across the entire product lifecycle.
Sustaining a robust benefit–risk profile requires senior expertise capable of integrating scientific evidence, safety data, real-world insights, and medical decision-making. This expertise is critical across initiatives including:
Positioning Medical Affairs, pharmacovigilance, and patient safety within an integrated medical governance framework
Alignment of medical, scientific, and safety functions
Strengthening evidence generation and medical decision-making
Management of pharmacovigilance, benefit–risk assessment, and safety governance
Embedding patient safety, medical integrity, and long-term stakeholder confidence
When the clinical value of a therapy must be sustained throughout its lifecycle.
The clinical value of a therapy is not determined solely at the point of regulatory approval. It is continuously reinforced through medical insight, safety data, and real-world experience across the entire product lifecycle.
Sustaining a robust benefit–risk profile requires senior expertise capable of integrating scientific evidence, safety data, real-world insights, and medical decision-making. This expertise is critical across initiatives including:
Positioning Medical Affairs, pharmacovigilance, and patient safety within an integrated medical governance framework
Alignment of medical, scientific, and safety functions
Strengthening evidence generation and medical decision-making
Management of pharmacovigilance, benefit–risk assessment, and safety governance
Embedding patient safety, medical integrity, and long-term stakeholder confidence
Domains in which we unlock senior expertise
Medical affairs & medical strategy
Medical affairs strategies
Scientific engagement and medical communications
Medical information and medical excellence
Patient safety & risk management
Risk management plans
Patient safety programmes
Safety monitoring throughout the product lifecycle
Farmacovigilantie en geneesmiddelenveiligheid
Pharmacovigilance systems
Signal detection and benefit–risk management
Safety governance and safety processes
Real World Evidence en medische inzichten
Real-world evidence (RWE)
Evidence generation and clinical outcomes
Medical data and evidence-based decision-making
Domains in which we unlock senior expertise
Medical affairs & medical strategy
Medical affairs strategies
Scientific engagement and medical communications
Medical information and medical excellence
Patient safety & risk management
Risk management plans
Patient safety programmes
Safety monitoring throughout the product lifecycle
Farmacovigilantie en geneesmiddelenveiligheid
Pharmacovigilance systems
Signal detection and benefit–risk management
Safety governance and safety processes
Real World Evidence en medische inzichten
Real-world evidence (RWE)
Evidence generation and clinical outcomes
Medical data and evidence-based decision-making
Domains in which we unlock senior expertise
Medical affairs & medical strategy
Medical affairs strategies
Scientific engagement and medical communications
Medical information and medical excellence
Patient safety & risk management
Risk management plans
Patient safety programmes
Safety monitoring throughout the product lifecycle
Farmacovigilantie en geneesmiddelenveiligheid
Pharmacovigilance systems
Signal detection and benefit–risk management
Safety governance and safety processes
Real World Evidence en medische inzichten
Real-world evidence (RWE)
Evidence generation and clinical outcomes
Medical data and evidence-based decision-making
Domains in which we unlock senior expertise
Medical affairs & medical strategy
Medical affairs strategies
Scientific engagement and medical communications
Medical information and medical excellence
Farmacovigilantie en geneesmiddelenveiligheid
Pharmacovigilance systems
Signal detection and benefit–risk management
Safety governance and safety processes
Patient safety & risk management
Risk management plans
Patient safety programmes
Safety monitoring throughout the product lifecycle
Real World Evidence en medische inzichten
Real-world evidence (RWE)
Evidence generation and clinical outcomes
Medical data and evidence-based decision-making
At the level the context requires
Executive and board level
Senior management level
Senior specialist level
At the level the context requires
Executive and board level
Senior management level
Senior specialist level
At the level the context requires
Executive and board level
Senior management level
Senior specialist level
At the level the context requires
Executive and board level
Senior management level
Senior specialist level
Scarce senior expertise in medical affairs & pharmacovigilance, unlocked through a discreet and carefully built professional ecosystem.
Schaarse senior expertise in medical affairs & pharmacovigilance, ontsloten via een discreet en zorgvuldig opgebouwd professioneel ecosysteem.
Engagement framework
01
Context determination
02
Selection at the appropriate level
03
Substantive alignment
04
Contractual anchoring
Engagement framework
01
Context determination
02
Selection at the appropriate level
03
Substantive alignment
04
Contractual anchoring
Engagement framework
01
Context determination
02
Selection at the appropriate level
03
Substantive alignment
04
Contractual anchoring
Engagement framework
01
Contextbepaling
02
Selectie op niveau
03
Inhoudelijke afstemming
04
Contractual anchoring
Discuss your medical affairs challenge
Discuss your medical affairs challenge
Discuss your medical affairs challenge
Discuss your medical affairs challenge
Knowledge & insights in medical affairs & pharmacovigilance
Medical Affairs & Pharmacovigilance
The strategic evolution of Medical Affairs & Pharmacovigilance: from supporting function to driver of scientific and commercial value
Read
Medical Affairs & Pharmacovigilance
Pharmacovigilance in the era of advanced therapies: safeguarding safety in an increasingly complex healthcare landscape
Read
Medical Affairs & Pharmacovigilance
How medical affairs and pharmacovigilance work together to improve patient outcomes
Read
Knowledge & insights in medical affairs & pharmacovigilance
Medical Affairs & Pharmacovigilance
The strategic evolution of Medical Affairs & Pharmacovigilance: from supporting function to driver of scientific and commercial value
Read
Medical Affairs & Pharmacovigilance
Pharmacovigilance in the era of advanced therapies: safeguarding safety in an increasingly complex healthcare landscape
Read
Medical Affairs & Pharmacovigilance
How medical affairs and pharmacovigilance work together to improve patient outcomes
Read
Knowledge & insights in medical affairs & pharmacovigilance
Medical Affairs & Pharmacovigilance
The strategic evolution of Medical Affairs & Pharmacovigilance: from supporting function to driver of scientific and commercial value
Read
Medical Affairs & Pharmacovigilance
Pharmacovigilance in the era of advanced therapies: safeguarding safety in an increasingly complex healthcare landscape
Read
Medical Affairs & Pharmacovigilance
How medical affairs and pharmacovigilance work together to improve patient outcomes
Read
Knowledge & insights in medical affairs & pharmacovigilance
Medical Affairs & Pharmacovigilance
The strategic evolution of Medical Affairs & Pharmacovigilance: from supporting function to driver of scientific and commercial value
Read
Medical Affairs & Pharmacovigilance
Pharmacovigilance in the era of advanced therapies: safeguarding safety in an increasingly complex healthcare landscape
Read
Medical Affairs & Pharmacovigilance
How medical affairs and pharmacovigilance work together to improve patient outcomes
Read
Our other domains of expertise
Strategic access to scarce senior life sciences expertise
Our other domains of expertise
Strategic access to scarce senior life sciences expertise
Our other domains of expertise
Strategic access to scarce senior life sciences expertise
Our other domains of expertise
Strategic access to scarce senior life sciences expertise
For Organizations
Contact
02 615 84 44
© 2018 – 2026 Maxwell Benson, a Benson Group company
For Organizations
Contact
02 615 84 44
© 2018 – 2026 Maxwell Benson, a Benson Group company
For Organizations
Contact
02 615 84 44
© 2018 – 2026 Maxwell Benson, a Benson Group company
For Organizations
© 2018 – 2026 Maxwell Benson, a Benson Group company